05/13/2025
4:04 PM | AbbVie (Issuer)
FALK THOMAS J (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
AUSTIN ROXANNE S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
BURNSIDE WILLIAM H.L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Davis Jennifer L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Hart Brett J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
MEYER MELODY B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
Roberts Rebecca B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
WADDELL FREDERICK H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for ABBV and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for AbbVie and its competitors with MarketBeat's FREE daily newsletter. |
05/13/2025
4:05 PM | AbbVie (Issuer)
FREYMAN THOMAS C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
TILTON GLENN F (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/13/2025
4:05 PM | AbbVie (Issuer)
FALK THOMAS J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/09/2025
12:24 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2025
6:48 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/31/2025
4:30 PM | AbbVie (Subject)
Stewart Jeffrey Ryan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/24/2025
6:40 PM | AbbVie (Filer)
| Form ARS | |
03/24/2025
3:28 PM | AbbVie (Filer)
| Form DEF 14A | |
03/24/2025
3:28 PM | AbbVie (Filer)
| Form DEFA14A | |
03/18/2025
4:00 PM | AbbVie (Issuer)
Reents Scott T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/14/2025
3:34 PM | AbbVie (Subject)
Reents Scott T (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025
4:05 PM | AbbVie (Filer)
| Form PRE 14A | |
03/10/2025
3:28 PM | AbbVie (Issuer)
Purdue David Ryan (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/03/2025
4:57 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:37 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/28/2025
4:00 PM | AbbVie (Issuer)
RICHMOND TIMOTHY J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
4:00 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/26/2025
4:47 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/20/2025
4:00 PM | AbbVie (Filer)
| Form 424B5 | |
02/19/2025
8:22 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/18/2025
8:25 PM | AbbVie (Subject)
| Form FWP | |
02/18/2025
7:41 AM | AbbVie (Filer)
| Form 424B5 | |
02/14/2025
12:17 PM | AbbVie (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2025
6:30 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2025
6:42 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/10/2025
7:31 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
4:00 PM | AbbVie (Issuer)
Buckbee Kevin K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
4:34 PM | AbbVie (Subject)
Buckbee Kevin K (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/04/2024
3:15 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/04/2024
3:16 PM | AbbVie (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
Silicon Valley Gold Rush (Ad) A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.”
Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free. Gates and Altman are betting big—see why |
11/04/2024
1:19 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2024
6:43 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Quaggin Susan E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
Alpern Robert J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
4:00 PM | AbbVie (Issuer)
RAPP EDWARD J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/30/2024
4:06 PM | AbbVie (Issuer)
SALEKI-GERHARDT AZITA (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/10/2024
2:30 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
4:40 PM | AbbVie (Subject)
Hudson Thomas J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
3:22 PM | AbbVie (Subject)
Hudson Thomas J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
2:00 PM | AbbVie (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
9:54 AM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024
6:41 AM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
3:40 PM | AbbVie (Issuer)
GONZALEZ RICHARD A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:17 PM | AbbVie (Subject)
GONZALEZ RICHARD A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/03/2024
1:07 PM | AbbVie (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
4:00 PM | AbbVie (Filer)
| Form 11-K
Annual reports of employee stock purchase, savings and similar plans pursuant to Section 15(d) | |
06/03/2024
10:28 AM | AbbVie (Subject)
NEW YORK STOCK EXCHANGE LLC (Filed by)
| Form 25-NSE | |
